BioSpace News Archive

Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), is delighted to announce that on February 17, 2022 the Company’s laboratory in Fitzroy, Melbourne has received simultaneous NATA accreditation and US Centers for Medicare and Medicaid Services (CMS) CLIA-certification enabling the commercial launch of the GeneType Multi-Test in Australia and the USA, respectively.

BostonGene today announced its publication, “Conserved pan-cancer microenvironment subtypes predict response to immunotherapy,” has been selected by Cancer Cell as one of ten research articles that represent cutting-edge areas of cancer research and oncology in 2021.

MedAvail Holdings, Inc. today announced the appointment of industry leaders Steven Hess to Executive Vice President, General Manager, of SpotRx and Bob McClune to Senior Vice President of Data and Analytics.

Moderna expects to enroll approximately 34,000 participants in multiple countries RSV causes severe disease burden among older adults and young children; there is no approved vaccine to prevent RSV.

Chinook Therapeutics, Inc. (NASDAQ: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced upcoming presentations at the 4th Annual Chronic Kidney Disease Drug Development (CKD) Summit in Boston from March 1 - 3, 2022.

Element Biosciences, Inc. today announced a partnership with New England Biolabs (NEB®) to commercially develop and launch products to enable compatibility of the NEBNext Ultra II portfolio with the Element AVITI System.

Secarna Pharmaceuticals GmbH & Co. KG today announced that Denali Therapeutics Inc. (“Denali”) has exercised its option to in-license an ASO program generated by Secarna through its proprietary drug discovery and development platform, LNAplusTM.

Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced that management will host a conference call and live audio webcast at 10:00 a.m. ET on March 1, 2022, to provide a business update and review the company’s financial results for the fourth quarter and year ended December 31, 2021.

Acer Therapeutics Inc. announced the appointment of Adrian Quartel, M.D., FFPM, as Chief Medical Officer.

Ageless Biotech, Inc. Sheridan, WY a biotech company created to bring stem cell-based therapeutics to market, has acquired a U.S. Food and Drug Administration (FDA) Investigational New Drug Application (IND) for the treatment of Osteoarthritis of the Knee.